Wellington Management Group LLP Decreases Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wellington Management Group LLP decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 74.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,604 shares of the company's stock after selling 65,354 shares during the period. Wellington Management Group LLP's holdings in Prestige Consumer Healthcare were worth $1,765,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Allspring Global Investments Holdings LLC boosted its position in shares of Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock worth $126,274,000 after purchasing an additional 49,331 shares in the last quarter. Geode Capital Management LLC boosted its stake in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company's stock worth $95,678,000 after purchasing an additional 50,961 shares in the last quarter. Congress Asset Management Co. increased its stake in Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company's stock valued at $70,964,000 after purchasing an additional 43,619 shares in the last quarter. Boston Trust Walden Corp raised its holdings in shares of Prestige Consumer Healthcare by 43.5% in the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company's stock worth $64,942,000 after buying an additional 252,089 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Prestige Consumer Healthcare by 5.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after buying an additional 33,844 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 0.4 %

Shares of Prestige Consumer Healthcare stock traded up $0.30 during trading hours on Friday, reaching $80.10. 292,350 shares of the company were exchanged, compared to its average volume of 286,757. The firm has a market cap of $3.97 billion, a PE ratio of 18.76, a PEG ratio of 2.69 and a beta of 0.47. The stock's fifty day moving average is $84.16 and its 200 day moving average is $80.09. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

PBH has been the subject of several recent research reports. StockNews.com lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th. DA Davidson lifted their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Oppenheimer boosted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. Canaccord Genuity Group raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Finally, Royal Bank of Canada upped their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research report on Friday, March 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of "Hold" and a consensus target price of $93.33.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company's stock, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.